CID 153270

Pralnacasan

Structural Information

Molecular Formula
C26H29N5O7
SMILES
CCO[C@H]1[C@H](CC(=O)O1)NC(=O)[C@@H]2CCCN3N2C(=O)[C@H](CCC3=O)NC(=O)C4=NC=CC5=CC=CC=C54
InChI
InChI=1S/C26H29N5O7/c1-2-37-26-18(14-21(33)38-26)29-23(34)19-8-5-13-30-20(32)10-9-17(25(36)31(19)30)28-24(35)22-16-7-4-3-6-15(16)11-12-27-22/h3-4,6-7,11-12,17-19,26H,2,5,8-10,13-14H2,1H3,(H,28,35)(H,29,34)/t17-,18-,19-,26+/m0/s1
InChIKey
CXAGHAZMQSCAKJ-WAHHBDPQSA-N
Compound name
(4S,7S)-N-[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]-7-(isoquinoline-1-carbonylamino)-6,10-dioxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide
Related CIDs

2D Structure

compound 2d structure
5
Annotation Hits

24
References

2048
Patents

523.2067 Da
Monoisotopic Mass

0.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 524.21398 223.1
[M+Na]+ 546.19592 224.6
[M-H]- 522.19942 231.2
[M+NH4]+ 541.24052 225.3
[M+K]+ 562.16986 226.7
[M+H-H2O]+ 506.20396 211.4
[M+HCOO]- 568.20490 231.7
[M+CH3COO]- 582.22055 249.8
[M+Na-2H]- 544.18137 219.4
[M]+ 523.20615 218.0
[M]- 523.20725 218.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe